Company: AEMD
Filing Date: 2025-09-05
Form Type: 424B4
Source: 0001683168-25-006701
Chunk: 40

Company: AETHLON MEDICAL INC
Filing Date: 2025-09-05
Form: 424B4
Chunk 40
---
 to comply with                                                                                             
 the continued listing requirements of the Nasdaq Capital Market and maintain our listing on the Nasdaq Capital Market; |
| · | our expectations regarding                                                                                             
 growth potential for our business in the organ transplant setting;                                                     |
| · | our ability to secure regulatory                                                                                       
 clearance or approval, domestically and internationally, for the clinical use of our products;                         |
| · | any estimates regarding                                                                                                
 expenses, future revenue and capital requirements;                                                                     |
| · | our ability to protect                                                                                                 
 our proprietary technology through patent protection;                                                                  |
| · | our product liability exposure;                                                                                        |
| · | our ability to sustain                                                                                                 
 and manage growth, including our ability to develop new products and enter new markets;                                |
| · | our ability to achieve                                                                                                 
 sufficient market acceptance of any of our products or product candidates; and                                         |
| · | our expected net proceeds                                                                                              
 from this offering and the use of the net proceeds from this offering.                                                 |

In some cases, you can identify
these statements by terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,”
“intend,” “may,” “plan,” “potential,” “predict,” “continue,”
“seek,” “project,” “should,” “will,” “would” or the negative of those terms,
and similar expressions. You should be aware that the occurrence of any of the events discussed under the heading “Risk Factors” in this prospectus and any documents incorporated by reference herein could substantially harm our business, operating
results and financial condition and that if any of these events occurs, it could adversely affect the value of an investment in our common
stock. In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant
subject. These statements are based upon information available to us as of the date the statement is made, and while we believe such
information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not
be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information.
In addition, even if our results of operations, financial condition and cash flows and the development of the markets in which we operate,
are consistent with the forward-looking statements contained in this prospectus, those results or developments may not be indicative
of results or developments in subsequent periods. New factors emerge from time to time that may cause our business not to develop as